Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
18.59
-0.73 (-3.78%)
Oct 2, 2026, 3:30 PM EDT - Market open
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $3.6 billion as of October 2, 2026. Its market cap has decreased by -40.59% in one year.
Market Cap
3.60B
Enterprise Value
2.92B
1-Year Change
-40.59%
Ranking
Category
Stock Price
$18.59
ChartMarket Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from $4.79B to $3.60B, a decrease of -24.74%. That is a compound annual growth rate of -4.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 3.85B | -4.01% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Parabilis Medicines | 3.94B |
| Celcuity | 3.79B |
| Telix Pharmaceuticals | 3.73B |
| Viking Therapeutics | 3.71B |
| IDEAYA Biosciences | 3.65B |
| Xenon Pharmaceuticals | 3.61B |
| Acadia Pharmaceuticals | 3.48B |
| Enliven Therapeutics | 3.41B |